Completing data — refresh the page later to see the latest
478148-58-2Cl.Cl.O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1IPKZCLGGYKRDES-ZDUSSCGKSA-N478148-58-2UsesPHA-543613 is a potent selective α7 nAChR agonist. Nicotinic acetylcholine receptors are ligand-gated ion channels activated by nicotine, expressed in multiple tissues, with high functional expression in brain. The homomeric subtype α7 is a potential therapeutic target for cognitive deficits in schizophrenia and Alzheimer′s disease. PHA-543613 is active in both in vitro (binding, calcium flux, patch-clamp) and in vivo (auditory gating, novel object recognition) assays.